Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro
- 30 June 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 31 (1-2) , 59-67
- https://doi.org/10.1016/0166-3542(96)00947-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- FoscarnetDrugs, 1991
- Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: Anti-HIV activity, physical properties, and interaction with plasma proteinsBiochemical and Biophysical Research Communications, 1990
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- Rapid isolation of cloned isotype switch variants using fluorescence activated cell sortingCytometry, 1982
- Antiviral effects of phosphonoformate (PFA, foscarnet sodium)Pharmacology & Therapeutics, 1982
- The antiherpesvirus action of phosphonoacetatePharmacology & Therapeutics, 1979
- Phosphonoformate Inhibits Reverse TranscriptaseJournal of General Virology, 1979
- Trisodium Phosphonoformate, a New Antiviral CompoundScience, 1978
- Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acidJournal of Medicinal Chemistry, 1977
- Effective Antiviral Chemotherapy in Cytomegalovirus Infection of MiceThe Journal of Infectious Diseases, 1976